Stock Spotlights Archives - Page 4 of 19

MondayFeb 12, 2024 3:34 pm

TinyGemsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Patented DehydraTECH(TM) Improves Delivery of GLP-1 Drug to Bloodstream

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, announced the final results from its completed human Pilot Study #1 that sought to evaluate the effectiveness of its patented DehydraTECH(TM) technology on the oral delivery of the glucagon-like peptide-1 (“GLP-1”) drug semaglutide, available commercially in the branded product Rybelsus(R). “Most notable from its pilot study was the improved delivery of semaglutide to the bloodstream, which significantly improved blood sugar control. For one, in just 20 minutes after oral administration, the DehydraTECH-GLP-1 blood semaglutide level was about 261% higher than that of the control, a statistic that reflected…

WednesdayFeb 07, 2024 2:58 pm

TinyGemsBreaks – GEMXX Corp. (GEMZ) Continues to Enhance Long-Term Asset Expansion Plan

GEMXX (OTC: GEMZ) is a mine-to-market company that focuses on producing gold, gemstone and jewelry from its own land resources. GEMXX last year acquired a 50% interest in Crazy Horse Mining Inc. (“CHMI”), a Canadian exploration company that owns 100% interest in two gold projects in British Columbia (Snow Creek and Rosella Creek), as well as signed a binding letter of intent to acquire a 50% interest in the historic Yukon Gold Project, which holds 2,210,660 ounces of proven gold resources. “The acquisition [of the Yukon Gold Project] is pending, awaiting the completion of due diligence and verification of the…

TuesdayFeb 06, 2024 3:32 pm

TinyGemsBreaks – Vision Marine Technologies Inc. (NASDAQ: VMAR) Disrupting Traditional Boating Industry with Electric Power

Vision Marine Technologies Inc. (NASDAQ: VMAR) is dedicated to pioneering the clean-energy transition on the water. “Boating magazine announced its Boat of the Year category winners for 2023, and the Four Winns H2e came out on top in the Runabout category. The Four Winns bowrider is powered by Vision Marine Technologies’ E-Motion, a 180 HP electric onboard engine that is the most powerful marine electric powertrain in the world,” a recent article reads. “The Four Winns H2e E-Motion engine is only a small piece of what VMAR does. As the global leader in the electric recreational boating industry serving both…

FridayJan 12, 2024 3:00 pm

TinyGemsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Positioned as Go-to Logistics Solution Within USMCA Region

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a tech company reforming cross-border shipping, recently announced the renewed selection of its Fr8App for Amazon Mexico’s domestic shipping within the USMCA region. “This marks the second year that Amazon Mexico has contracted Fr8Tech, in what the CEO Javier Selgas has attributed to the company’s commitment to meeting customers’ needs and continuously improving its platform. This announcement comes just months after Fr8Tech announced the securing of a Request for Quotation (‘RFQ’) from a leading global pharmaceutical giant, for which it was awarded 33 lanes to transport pharmaceutical goods from the U.S. to both Mexico and…

FridayJan 12, 2024 2:29 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Looking to Grow Revenue and Commercial Opportunities Through Licensing

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, is committed to providing healthier delivery methods of drugs and other active pharmaceutical ingredients (“APIs”) through its patented drug delivery technology, DehydraTECH(TM). “The company’s efforts have focused on several key segments, including hypertension, diabetes, antivirals, epilepsy, nicotine replacement, and more. This has been an ongoing process since 2016, with positive results achieved from various clinical studies thus far, showing up to 17x brain absorption improvements for oral administration of APIs… Human clinical studies have been conducted since 2018, with more on the way,” a recent article reads. “With…

ThursdayJan 11, 2024 3:39 pm

TinyGemsBreaks – Diamond Lake Minerals Inc.’s (DLMI) Renewed Focus, New Team Driving Significant Growth

Diamond Lake Minerals (OTC: DLMI), a multi-strategy operating company, is experiencing rapid growth in the wake of its reinvention from a mining holding enterprise to the digital asset and security token space. The attention security tokens and tokenized securities are gaining are drivers of evolution in the companies’ investment platforms. “Diamond Lake Minerals is developing its operation by building a vertically integrated ecosystem of numerous industry agnostic holdings and imbuing each with an SEC-registered security token offering (‘STO’). The result is a portfolio of widely varied subsidiaries that will share resources and support one another while they’re growing and developing…

TuesdayDec 26, 2023 3:40 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Leveraging Commercial Viability of DehydraTECH(TM) in Aggressive Patent Application Push

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, is eyeing growth in license revenue from its intellectual property (“IP”). “So far, Lexaria has received 37 granted patents globally, with many pending. The company is aggressively pushing its patent application process as it recognizes the viable commercial application of its flagship technology. In addition, the company understands that successfully granted patents can lead to an increase in shareholder value as a recognized growing market leader,” a recent article reads. “‘Because of the applicability of DehydraTECH to many market sectors across the globe, we have taken the necessary…

FridayDec 15, 2023 3:28 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Targeting New and More Lucrative Global Markets

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, is exploring the impact of its patented DehydraTECH(TM) technology on the oral performance of GLP-1 drugs for the treatment of diabetes and weight loss. “The move could help Lexaria carve out an important market share for an industry that is projected to bring in between $150 billion and $200 billion a year. Given the positive results the company has achieved so far in its diabetes and hypertension clinical studies, Lexaria is optimistic that its foray into GLP-1 drugs will yield positive results and open up its technology to…

WednesdayNov 15, 2023 3:26 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Continues to Advance Patented DehydraTECH(TM)

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, is steadily advancing its patented DehydraTECH(TM) technology for a growing range of applications including oral nicotine, hypertension, antivirals, human hormone therapy, diabetes and more. Through previous clinical trials, DehydraTECH-processed CBD has shown its ability to lower blood pressure in patients over multiple weeks. “That we were able to lower blood pressure in our patient population over multiple weeks using DehydraTECH-CBD is an exceptional discovery, given that previous studies by others using other oral CBD formulations have failed to evidence this sustained benefit,” a recent article quotes Lexaria CEO…

FridayNov 03, 2023 2:52 pm

TinyGemsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM)-Processed CBD Proven Superior in Research

Lexaria (NASDAQ: LEXX), a global innovator in drug delivery platforms, remains on track to submit an Investigational New Drug (“IND”) application for its planned U.S. Phase 1b Hypertension Clinical Trial HYPER H23-1. “Lexaria’s IND submission builds on five previous human clinical studies conducted from 2018 to 2022 and is integral to the successful filing and review of the submission. These studies were carried out in an aggregate total of 134 healthy and hypertensive persons and evidenced significant reductions in resting blood pressure over both acute and multi-week dosing regimens… The company is only aware of a handful of other published…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

Breaks Categories: Stock Spotlights